Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of …,

Antengene is currently conducting five late-stage clinical trials of selinexor for the treatment of MM, DLBCL, non-small cell lung cancer, and peripheral T …, Antengene is currently conducting five late-stage clinical trials of selinexor for the treatment of MM, DLBCL, non-small cell lung cancer, and peripheral T …, Read More

Scroll to Top